Skip to main content

Table 1 Patients demographics and clinical characteristics

From: Evaluation of a combination “lymphocyte apoptosis model” to predict survival of sepsis patients in an intensive care unit

Variables

total (n = 52)

the Survival group (n = 35)

the non-survival group (n = 17)

p

Age (yrs), mean ± SD

62.4 ± 20.3

57.0 ± 21.8

73.3 ± 10.4

0.001

male

40(76.9)

26(74.3)

14(82.4)

0.729

APACHE II score, mean ± SD

13.2 ± 5.7

12.0 ± 5.8

15.8 ± 4.7

0.024

SOFA score, mean ± SD

4.2 ± 2.0

3.9 ± 1.8

4.8 ± 2.3

0.106

GCS score, mean ± SD

11.3 ± 3.6

11.7 ± 3.2

10.6 ± 4.2

0.290

Preexisting clinical conditions

 Diabetes

10(19.2)

9(25.7)

1(5.9)

0.137

 Respiratory

15(28.8)

8(22.9)

7(41.2)

0.203

 Cardiovascular

8(15.4)

5(19.2)

3(19.2)

1.000

 Neurological

13(25.0)

9(25.7)

4(23.5)

1.000

 Multitrauma

9(17.3)

5(14.3)

4(23.5)

0.451

 Other

4(7.7)

3(8.6)

1(5.9)

1.000

Sites of infection, n (%)

 Pulmonary

26(50.0)

14(40.0)

12(70.6)

0.518

 blood

6(11.5)

4(11.4)

2(11.8)

1.000

 Abdomen

4(7.7)

3(8.6)

1(5.9)

1.000

 thoracic cavity

3(5.8)

3(8.6)

0

 Urinary tract

2(3.8)

2(5.7)

0

 Soft tissue

4(7.7)

3(8.6)

1(8.6)

1.000

 Biliary tract

4(7.7)

3(8.6)

1(8.6)

1.000

 CNS infections

3(5.8)

3(8.6)

0

  1. Values are expressed as the mean ± SD or n (%). APACHE acute physiology and chronic health evaluation, CNS central nervous system, GCS glasgow coma scale, SD standard deviation, SOFA sequential organ failure assessment